# Biomarker Development for Autoimmune Disorders Involving the Kidneys

> **NCT07666711** · — · RECRUITING · sponsor: **Oslo University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Lupus Nephritis
- Systemic Lupus Erythematosus

## Interventions

- **DIAGNOSTIC_TEST:** Longitudinal Blood and Urine Biomarker Monitoring

## Key facts

- **NCT ID:** NCT07666711
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2031-06-14
- **Final completion:** 2031-06-14
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07666711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07666711, "Biomarker Development for Autoimmune Disorders Involving the Kidneys". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07666711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*